Alzheimer's Disease (AD) Clinical Trials


Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

Condition:   Mild-moderate Alzheimer's Disease
Interventions:   Drug: Donepezil;   Drug: DHP1401;   Drug: Placebo
Sponsor:   Daehwa Pharmaceutical Co., Ltd.
Recruiting - verified April 2017

Learn More

Study to Evaluate the Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease

Condition:   Mild to Moderate Alzheimer's Disease
Intervention:   Drug: Rivastigmine Patch
Sponsor:   Novartis Pharmaceuticals
Recruiting - verified November 2016

Learn More

Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease

Condition:   Alzheimer's Disease
Interventions:   Biological: UCMSCs;   Biological: Placebo
Sponsors:   South China Research Center for Stem Cell and Regenerative Medicine;   Third Affiliated Hospital, Sun Yat-Sen University;   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University;   Guangzhou Psychiatric Hospital
Not yet recruiting - verified January 2016

Learn More

Omental Transposition Surgery for Mild Alzheimer's Disease

Condition:   Alzheimer's Disease
Intervention:   Procedure: Omental transposition for mild Alzheimers disease
Sponsor:   Bariatric Medicine Institute, Salt Lake City, UT
Not yet recruiting - verified March 2016

Learn More

The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease

Condition:   Alzheimer's Disease
Intervention:   Device: Deep Brain Stimulation (Beijing PINS Medical Co., Ltd)
Sponsors:   Beijing Pins Medical Co., Ltd;   Beijing Tiantan Hospital
Recruiting - verified January 2016

Learn More

A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients

Condition:   Alzheimer's Disease
Intervention:   Drug: Aricept
Sponsor:   Eisai Korea Inc.
Completed - verified February 2017

Learn More

A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease

Conditions:   Alzheimer's Disease;   Dementia
Interventions:   Drug: Drug: NIC5-15;   Drug: Placebo
Sponsors:   Humanetics Corporation;   National Center for Complementary and Integrative Health (NCCIH);   James J. Peters Veterans Affairs Medical Center
Completed - verified October 2016

Learn More

What Elements of the Design of a Healing Garden Are Used as Landmarks by Patients With Alzheimer's Disease to Locate?

Condition:   Alzheimer Disease
Intervention:   Other: neuropsychological assessment
Sponsor:   Central Hospital, Nancy, France
Completed - verified July 2015

Learn More

Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient

Condition:   Alzheimer's Disease
Interventions:   Biological: GSK933776;   Biological: GSK933776;   Biological: GSK933776
Sponsor:   GlaxoSmithKline
Completed - verified January 2017

Learn More

Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

Condition:   Alzheimer's Disease
Interventions:   Drug: Sagramostim;   Drug: Saline -- placebo comparator
Sponsors:   University of Colorado, Denver;   The Dana Foundation
Active, not recruiting - verified May 2017

Learn More

Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia

Conditions:   Alzheimer's Disease;   Dementia
Intervention:   Drug: donepezil
Sponsors:   Samsung Medical Center;   Eisai Korea Inc.
Completed - verified January 2016

Learn More

Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)

Condition:   Alzheimer's Disease
Interventions:   Biological: Clinic and neuropsychologic evaluation;   Radiation: MRI;   Procedure: PET;   Biological: Apolipoprotein E genotyping;   Biological: Study of cerebrospinal fluid
Sponsor:   Assistance Publique Hopitaux De Marseille
Recruiting - verified October 2015

Learn More

Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)

Condition:   Alzheimer's Disease
Intervention:  
Sponsor:   Orasi Medical, Inc.
Completed - verified August 2010

Learn More

A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

Condition:   Alzheimer's Disease
Interventions:   Biological: PF-04360365 10 mg/kg;   Biological: PF-04360365 7.5 mg/kg;   Drug: placebo
Sponsor:   Pfizer
Completed - verified June 2011

Learn More

Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

Condition:   Alzheimer's Disease
Interventions:   Genetic: CERE-110: Adeno-Associated Virus Delivery of NGF;   Procedure: Placebo Surgery
Sponsors:   Sangamo Therapeutics;   Alzheimer's Disease Cooperative Study (ADCS)
Active, not recruiting - verified January 2017

Learn More

1-15 of 48
Results per page

Join the community!


You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.